HUBEI GOTO BIOPHARHUBEI GOTO BIOPHARHUBEI GOTO BIOPHAR

HUBEI GOTO BIOPHAR

No trades
See on Supercharts
Market capitalization
‪2.15 B‬CNY
−0.12CNY
‪23.01 M‬CNY
‪565.40 M‬CNY
‪104.03 M‬
Beta (1Y)
1.36
Employees (FY)
631
Change (1Y)
+94 +17.50%
Revenue / Employee (1Y)
‪126.21 K‬CNY
Net income / Employee (1Y)
‪5.14 K‬CNY

About HUBEI GOTO BIOPHAR


CEO
Zu Bin Xi
Headquarters
Xiangyang
Founded
2006
ISIN
CNE100004K94
FIGI
BBG00TP4M979
Hubei Goto Biopharm Co., Ltd. engages in the research, development, production, and sale of steroidal drug raw materials. The company was founded by Zu Bin Xi on May 15, 2006 and is headquartered in Xiangyang, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 300966 is 18.72 CNY — it has increased by 0.43% in the past 24 hours. Watch HUBEI GOTO BIOPHAR stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HUBEI GOTO BIOPHAR stocks are traded under the ticker 300966.
300966 stock has fallen by −4.25% compared to the previous week, the month change is a 1.19% rise, over the last year HUBEI GOTO BIOPHAR has showed a −24.94% decrease.
300966 reached its all-time high on Apr 9, 2021 with the price of 79.98 CNY, and its all-time low was 12.03 CNY and was reached on Feb 8, 2024. View more price dynamics on 300966 chart.
See other stocks reaching their highest and lowest prices.
300966 stock is 2.16% volatile and has beta coefficient of 1.36. Track HUBEI GOTO BIOPHAR stock price on the chart and check out the list of the most volatile stocks — is HUBEI GOTO BIOPHAR there?
Today HUBEI GOTO BIOPHAR has the market capitalization of ‪2.15 B‬, it has decreased by −1.48% over the last week.
Yes, you can track HUBEI GOTO BIOPHAR financials in yearly and quarterly reports right on TradingView.
300966 net income for the last quarter is ‪−9.04 M‬ CNY, while the quarter before that showed ‪−8.67 M‬ CNY of net income which accounts for −4.36% change. Track more HUBEI GOTO BIOPHAR financial stats to get the full picture.
Yes, 300966 dividends are paid annually. The last dividend per share was 0.02 CNY. As of today, Dividend Yield (TTM)% is 0.09%. Tracking HUBEI GOTO BIOPHAR dividends might help you take more informed decisions.
HUBEI GOTO BIOPHAR dividend yield was 0.07% in 2023, and payout ratio reached 8.02%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 631.00 employees. See our rating of the largest employees — is HUBEI GOTO BIOPHAR on this list?
Like other stocks, 300966 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUBEI GOTO BIOPHAR stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUBEI GOTO BIOPHAR technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUBEI GOTO BIOPHAR stock shows the neutral signal. See more of HUBEI GOTO BIOPHAR technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.